Group One Trading’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-180,000
| Closed | -$9.3M | – | 8496 |
|
|
2022
Q3 | $9.3M | Sell |
180,000
-11,400
| -6% | -$471K | 0.02% | 770 |
|
|
2022
Q2 | $4.74M | Sell |
191,400
-52,900
| -22% | -$1.17M | 0.01% | 1328 |
|
|
2022
Q1 | $6.13M | Sell |
244,300
-124,200
| -34% | -$3.49M | 0.01% | 1381 |
|
|
2021
Q4 | $13.4M | Buy |
368,500
+143,900
| +64% | +$5.05M | 0.01% | 895 |
|
|
2021
Q3 | $3.84M | Buy |
224,600
+114,100
| +103% | +$1.78M | ﹤0.01% | 1978 |
|
|
2021
Q2 | $1.48M | Buy |
110,500
+97,400
| +744% | +$2.4M | ﹤0.01% | 2957 |
|
|
2021
Q1 | $671K | Sell |
13,100
-10,700
| -45% | -$644K | ﹤0.01% | 3699 |
|
|
2020
Q4 | $1.47M | Buy |
23,800
+16,300
| +217% | +$933K | ﹤0.01% | 2296 |
|
|
2020
Q3 | $411K | Sell |
7,500
-125,500
| -94% | -$6.76M | ﹤0.01% | 3021 |
|
|
2020
Q2 | $7.65M | Buy |
133,000
+55,700
| +72% | +$3.03M | 0.04% | 566 |
|
|
2020
Q1 | $3.11M | Buy |
77,300
+12,700
| +20% | +$539K | 0.03% | 777 |
|
|
2019
Q4 | $2.56M | Buy |
64,600
+53,300
| +472% | +$936K | 0.02% | 1108 |
|
|
2019
Q3 | $77K | Sell |
11,300
-8,600
| -43% | -$64.5K | ﹤0.01% | 3731 |
|
|
2019
Q2 | $185K | Sell |
19,900
-5,100
| -20% | -$59K | ﹤0.01% | 2919 |
|
|
2019
Q1 | $347K | Buy |
25,000
+1,000
| +4% | +$11.4K | ﹤0.01% | 2244 |
|
|
2018
Q4 | $262K | Sell |
24,000
-4,000
| -14% | -$42.2K | ﹤0.01% | 2476 |
|
|
2018
Q3 | $354K | Buy |
28,000
+8,900
| +47% | +$107K | ﹤0.01% | 2578 |
|
|
2018
Q2 | $252K | Buy |
19,100
+19,000
| +19,000% | +$227K | ﹤0.01% | 2875 |
|
|
2018
Q1 | $1K | Buy |
+100
| New | +$1.03K | ﹤0.01% | 4724 |
|
|
2017
Q1 | – | Sell |
-2,200
| Closed | -$16K | – | 5139 |
|
|
2016
Q4 | $16K | Buy |
2,200
+1,000
| +83% | +$7.2K | ﹤0.01% | 3796 |
|
|
2016
Q3 | $7K | Sell |
1,200
-20,000
| -94% | -$94.5K | ﹤0.01% | 4153 |
|
|
2016
Q2 | $95K | Buy |
+21,200
| New | +$79.6K | ﹤0.01% | 2903 |
|
|
2015
Q4 | – | Sell |
-14,000
| Closed | -$85K | – | 5223 |
|
|
2015
Q3 | $85K | Hold |
14,000
| – | – | ﹤0.01% | 3160 |
|
|
2015
Q2 | $115K | Buy |
14,000
+7,500
| +115% | +$59.6K | ﹤0.01% | 2970 |
|
|
2015
Q1 | $49K | Buy |
6,500
+400
| +7% | +$3.13K | ﹤0.01% | 3377 |
|
|
2014
Q4 | $42K | Buy |
6,100
+5,100
| +510% | +$27K | ﹤0.01% | 3493 |
|
|
2014
Q3 | $5K | Buy |
+1,000
| New | +$5.29K | ﹤0.01% | 4743 |
|
|
2014
Q2 | – | Sell |
-500
| Closed | -$3K | – | 5592 |
|
|
2014
Q1 | $3K | Sell |
500
-5,800
| -92% | -$40.3K | ﹤0.01% | 4946 |
|
|
2013
Q4 | $36K | Buy |
6,300
+3,100
| +97% | +$16K | ﹤0.01% | 3867 |
|
|
2013
Q3 | $18K | Buy |
+3,200
| New | +$34.6K | ﹤0.01% | 4235 |
|
Other funds holding CCXI
Group One Trading's CCXI Position: Q3 2022 in Review
Group One Trading sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 80,635 shares — an estimated $3.33M sold.
Group One Trading first reported a position in CCXI in Q4 2013 and held it in 18 quarters. The position peaked at $4.47M in Q3 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.
- Group One Trading reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
- Group One Trading sold 80,635 ChemoCentryx, Inc. shares in Q3 2022, an estimated $3.33M.
- Group One Trading first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 18 quarters.
- Group One Trading's ChemoCentryx, Inc. position peaked at $4.47M in Q3 2021.
- 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.
Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.